Mina Shahisavandi

742 total citations
16 papers, 469 citations indexed

About

Mina Shahisavandi is a scholar working on Infectious Diseases, Neurology and Psychiatry and Mental health. According to data from OpenAlex, Mina Shahisavandi has authored 16 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Neurology and 6 papers in Psychiatry and Mental health. Recurrent topics in Mina Shahisavandi's work include Long-Term Effects of COVID-19 (7 papers), COVID-19 Clinical Research Studies (5 papers) and Epilepsy research and treatment (4 papers). Mina Shahisavandi is often cited by papers focused on Long-Term Effects of COVID-19 (7 papers), COVID-19 Clinical Research Studies (5 papers) and Epilepsy research and treatment (4 papers). Mina Shahisavandi collaborates with scholars based in Iran, United States and Netherlands. Mina Shahisavandi's co-authors include Ali A. Asadi‐Pooya, Zohreh Barzegar, Hamid Nemati, Maryam Kabiri, Zahra Zeraatpisheh, Mahtab Rostamihosseinkhani, Ali Akbari, Masoume Nazeri, Anahita Jafari and Amir Emami and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Microbiology and Sleep Medicine Reviews.

In The Last Decade

Mina Shahisavandi

15 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mina Shahisavandi Iran	7	353	198	158	95	75	16	469
Zohreh Barzegar Iran	7	353 1.0×	199 1.0×	161 1.0×	96 1.0×	79 1.1×	13	468
Mayssam Nehme Switzerland	10	331 0.9×	165 0.8×	187 1.2×	72 0.8×	88 1.2×	44	487
Masoume Nazeri Iran	9	318 0.9×	134 0.7×	147 0.9×	94 1.0×	81 1.1×	30	498
Anahita Jafari United States	7	308 0.9×	136 0.7×	143 0.9×	93 1.0×	43 0.6×	13	435
Mahtab Rostamihosseinkhani Iran	6	313 0.9×	140 0.7×	141 0.9×	93 1.0×	48 0.6×	11	388
Lakshmi Manoharan Australia	4	504 1.4×	203 1.0×	266 1.7×	150 1.6×	87 1.2×	11	601
Tahmina Nasserie United States	5	369 1.0×	149 0.8×	207 1.3×	101 1.1×	78 1.0×	6	479
Melina Michelen United States	4	503 1.4×	196 1.0×	267 1.7×	151 1.6×	87 1.2×	10	585
Ariana Magedson United States	3	468 1.3×	270 1.4×	244 1.5×	125 1.3×	89 1.2×	4	605
Yuan Cen China	7	376 1.1×	125 0.6×	210 1.3×	159 1.7×	53 0.7×	9	460

Countries citing papers authored by Mina Shahisavandi

Since Specialization

Citations

This map shows the geographic impact of Mina Shahisavandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mina Shahisavandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mina Shahisavandi more than expected).

Fields of papers citing papers by Mina Shahisavandi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mina Shahisavandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mina Shahisavandi. The network helps show where Mina Shahisavandi may publish in the future.

Co-authorship network of co-authors of Mina Shahisavandi

This figure shows the co-authorship network connecting the top 25 collaborators of Mina Shahisavandi. A scholar is included among the top collaborators of Mina Shahisavandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mina Shahisavandi. Mina Shahisavandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Shahisavandi, Mina, et al.. (2025). Recreational cannabis use and sleep in the general population: a systematic review and meta-analysis. Sleep Medicine Reviews. 84. 102189–102189.

Shahisavandi, Mina, Kan Wang, Mohsen Ghanbari, & Fariba Ahmadizar. (2023). Exploring Metabolomic Patterns in Type 2 Diabetes Mellitus and Response to Glucose-Lowering Medications—Review. Genes. 14(7). 1464–1464. 12 indexed citations

Nemati, Hamid, et al.. (2022). Treatment of Child Gratification Disorder.. PubMed. 16(2). 9–16. 5 indexed citations

Shahisavandi, Mina, Mohammad Azizi, Said el Bouhaddani, et al.. (2022). The risk profile of patients with COVID-19 as predictors of lung lesions severity and mortality—Development and validation of a prediction model. Frontiers in Microbiology. 13. 893750–893750. 1 indexed citations

Asadi‐Pooya, Ali A., et al.. (2021). Smart devices/mobile phone in patients with epilepsy? A systematic review. Acta Neurologica Scandinavica. 144(4). 355–365. 2 indexed citations

Asadi‐Pooya, Ali A., et al.. (2021). Mask Wearing Hesitancy During the COVID-19 Pandemic in South Iran. Disaster Medicine and Public Health Preparedness. 16(5). 1789–1791. 3 indexed citations

Asadi‐Pooya, Ali A., et al.. (2021). COVID-19 Vaccine Hesitancy Among Patients With Epilepsy or Other Chronic Conditions. Disaster Medicine and Public Health Preparedness. 16(5). 1848–1850. 18 indexed citations

Shahisavandi, Mina, et al.. (2021). Treatment of postictal headache: a systematic review and future directions. Epilepsy & Behavior. 119. 107971–107971. 1 indexed citations

Asadi‐Pooya, Ali A., Hamid Nemati, Mina Shahisavandi, et al.. (2021). Long COVID in children and adolescents. World Journal of Pediatrics. 17(5). 495–499. 108 indexed citations

10.

Asadi‐Pooya, Ali A., Ali Akbari, Amir Emami, et al.. (2021). Long COVID syndrome‐associated brain fog. Journal of Medical Virology. 94(3). 979–984. 157 indexed citations

11.

Ghasemiyeh, Parisa, Negar Mortazavi, Iman Karimzadeh, et al.. (2021). Psychiatric Adverse Drug Reactions and Potential Anti-COVID-19 Drug Interactions with Psychotropic Medications.. PubMed. 20(3). 66–77. 6 indexed citations

12.

Asadi‐Pooya, Ali A., Seyed Ali Nabavizadeh, Saeid Sadeghian, et al.. (2021). Psychological Problems Among Patients With Chronic Medical Disorders During the COVID-19 Pandemic. SHILAP Revista de lepidopterología. 4 indexed citations

13.

Asadi‐Pooya, Ali A., Ali Akbari, Amir Emami, et al.. (2021). Risk Factors Associated with Long COVID Syndrome: A Retrospective Study.. SHILAP Revista de lepidopterología. 46(6). 428–436. 93 indexed citations

14.

Shafiekhani, Mojtaba, et al.. (2021). Pharmacotherapeutic approach toward urological medications and vaccination during COVID-19: a narrative review. Therapeutic Advances in Urology. 13. 3613393290–3613393290. 1 indexed citations

15.

Asadi‐Pooya, Ali A., et al.. (2020). Is the risk of COVID-19 contraction increased in patients with epilepsy?. Epilepsy & Behavior. 115. 107734–107734. 8 indexed citations

16.

Asadi‐Pooya, Ali A., Leila Simani, Mina Shahisavandi, & Zohreh Barzegar. (2020). COVID-19, de novo seizures, and epilepsy: a systematic review. Neurological Sciences. 42(2). 415–431. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact